在心力衰竭患者管理中收集和实施床旁超声数据的工作流程和框架
July 12th, 2024
1.4K views
该协议为在住院和门诊心力衰竭患者的管理中使用床旁超声提供了一种可扩展的工作流程。
我们的工作旨在展示一种获取 POCUS 数据并将其集成到电子健康记录中以管理心力衰竭患者的工作流程。我们打算分享我们已开发和标准化的工作流程，作为将 POCUS 数据纳入心力衰竭管理的模板。目前的一些实验挑战包括获得低成本的 POCUS 设备、不同的用户专业知识、专家指导的可用性有限以及在临床护理环境中实施的易于整合的 POCUS 工作流程数量有限。
我们的协议演示了将实时 POCUS 数据集成到实时电子病历中的工作流程。这包括可以针对个体患者进行比较和观察的图像和测量值，反映治疗时的生理变化和对心力衰竭的反应。该工作流程允许对心力衰竭患者进行比较、前瞻性评估。
它还为开发 POCUS 治疗的心力衰竭患者数据库提供了一条途径。
概览
该协议展示了在管理心力衰竭患者中使用床旁超声（POCUS）的可扩展工作流程。它详细说明了将POCUS数据集成到电子健康记录中以增强患者护理。
关键研究组成部分
科学领域
- 心脏病学
- 超声技术
- 患者管理
背景
- 心力衰竭管理需要有效的监测和评估技术。
- 床旁超声（POCUS）提供实时成像以辅助临床决策。
- 挑战包括设备的可及性和用户专业知识。
- 标准化工作流程对于在临床环境中有效实施至关重要。
研究目的
- 展示获取心力衰竭管理POCUS数据的工作流程。
- 标准化将POCUS数据集成到电子健康记录中。
- 促进心力衰竭患者的比较评估。
使用的方法
- 为获得最佳成像定位患者。
- 对不同组织类型使用适当的超声探头和设置。
- 在电子健康记录中记录发现。
- 使用后清洁和维护超声设备。
主要结果
- 成功将POCUS数据集成到患者记录中。
- 通过成像识别胸腔积液和中心静脉压。
- 创建POCUS治疗的心力衰竭患者数据库。
- 基于实时数据增强临床决策。
结论
- 标准化工作流程改善了心力衰竭管理。
- 实时POCUS数据增强了患者监测和治疗。
- 未来的研究可以在此协议基础上进一步完善心力衰竭护理。
常见问题
什么是POCUS？
床旁超声（POCUS）是一种在床边使用的诊断成像技术，用于提供患者状况的实时信息。
POCUS如何使心力衰竭患者受益？
POCUS允许立即评估心脏功能和液体状态，有助于及时的临床决策。
实施POCUS的挑战是什么？
挑战包括设备可及性、不同用户专业知识以及标准化工作流程的需求。
POCUS数据如何集成到电子健康记录中？
POCUS数据记录在电子健康记录中的预建字段中，允许轻松访问和审查。
使用POCUS可以进行哪些类型的测量？
测量包括下腔静脉（IVC）尺寸和胸腔积液的存在。
使用POCUS需要培训吗？
是的，培训对于确保准确的成像和结果解释至关重要。
Executive Industry Relevance
Standardized integration of point-of-care ultrasound (POCUS) data into electronic health records enables real-time, quantitative monitoring of physiological changes in heart failure patients. This workflow supports scalable, reproducible data capture for longitudinal assessment and treatment response, directly impacting predictive confidence in clinical management. The approach provides a template for enterprise-level adoption of imaging biomarkers in disease monitoring pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables objective, serial measurement of physiological parameters relevant to disease progression.
- Supports biological de-risking by providing real-time imaging data for functional validation.
- Facilitates hypothesis testing regarding treatment effects on central venous pressure and fluid status.
Screening & Assay Development
- Standardizes imaging data collection for reproducible quantitative outputs across patient cohorts.
- Prepares validated imaging endpoints for downstream analysis and comparison.
- Enables scalable data capture suitable for integration into digital health platforms.
Translational & Preclinical Research
- Aligns imaging biomarkers with clinical endpoints for translational continuity.
- Supports risk-adjusted advancement decisions by providing actionable, patient-level data.
- Facilitates database creation for retrospective and prospective analyses of treatment response.
Pipeline & Workflow Integration
This POCUS workflow bridges clinical data acquisition with digital record integration, supporting discovery through translational research phases.
- Discovery Biology: Provides real-time physiological readouts for hypothesis testing and pathway clarification.
- Screening: Delivers standardized, reproducible imaging data for quantitative assessment.
- Analytics: Enables direct comparison of serial measurements and treatment responses.
- Translational Research: Connects imaging endpoints to clinical management and outcome tracking.
- Enterprise Reuse: Establishes a scalable framework for imaging data integration across studies and sites.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in patient monitoring.
- Operational Value: Promotes standardization, reproducibility, and scalability of imaging workflows.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling timely, data-driven interventions.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of digital health-enabled monitoring strategies.
Implementation Considerations
- Requires expertise in ultrasound imaging and data interpretation.
- Needs access to calibrated POCUS devices and electronic health record integration.
- Demands cross-team standardization of data fields and workflow steps.
- Must adapt protocols for different patient populations and clinical settings.
- Considers limitations in device availability and user training as operational barriers.
Biopharma FAQs
Why does null hypothesis testing matter for IVC measurement in POCUS?
Null hypothesis testing ensures that observed changes in IVC diameter are statistically significant and not due to random variation, supporting robust target validation in heart failure monitoring workflows.
How does independent variable isolation apply to serial IVC imaging?
Isolating variables such as patient posture and probe settings during serial IVC imaging enables accurate attribution of physiological changes to treatment interventions, strengthening discovery-stage data integrity.
What do quantitative dependent variable measurements of IVC diameter enable?
Quantitative IVC measurements provide objective, reproducible endpoints for assessing volume status and treatment response, facilitating data-driven clinical and translational research decisions.
Why are replication requirements critical for POCUS workflow standardization?
Replication ensures that POCUS-acquired data are consistent across users and time points, enabling reliable cross-functional collaboration and multi-site data integration.
Which statistical analysis capabilities are needed before implementing POCUS data integration?
Robust statistical tools are required to analyze serial imaging data, compare treatment effects, and validate the reproducibility of POCUS-derived endpoints prior to broader workflow adoption.
